Applications published 18 November 2009

Long-chain alcohol derivatives for the treatment of alopecia areata
Yeda Research and Development 2117301*

Drug substance preparation, pharmaceutical compsns and dosage forms
Myriad Genetics 2117302*

Methods for treating psoriasis
Abbott Laboratories 2117303*

Methods and compsns for modulating sialic acid production and treating hereditary inclusion body myopathy
Gradalis 2117304*

Modification of exosomal components for use as a vaccine
University of Louisville Research Foundation 2117305*

Neurogenic compounds
Mars Inc; The Salk Institute of Biological Sciences 2117306*

Polymorphs and solvates of a pharmaceutical and methods of making
Biogen Idec; Vernalis Research 2117308*

Bicyclic spiorpiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
Merck 2117309*

Therapeutic agents
Merck 2117311*

Pharmaceuticals, compsns and methods of making and using the same
Biogen Idec; Vernalis Research 2117313*

Adamantanamines and reamexane salts of thiomolybdic and thio-tungstic acids
SSV Therapeutics 2117315*

• Use of derivatives of 4-hydroxyphenoxy acetic acid
Cognis IP Management 2117498*

• Use of derivatives of sinapinic acid and compsns comprising such derivatives
Cognis IP Management 2117499*

• Dermal film-forming liquid formulations for drug release to skin
Polichem 2117500*

• Compsn for combating epistaxis
Pharmacure Health Care 2117502*

• A controlled release compsn comprising a recombinant gelatin
Fujifilm Imagine Colorants 2117503*

• Stable pharmaceutical aerosols
Schering 2117504*

• Methods of making pharmaceutical components for customised drug products
Tuel, Stephen 2117506*

• Compsns for aerosolisation of highly conductive solutions
Battelle Memorial Institute 2117507*

• Intravenous solutions comprising ranolazine
CV Therapeutics 2117508*

• Use of ranolazine for the treatment of cardiovascular diseases
CV Therapeutics 2117509*

• Parenteral pharmaceutical compsn and method for preparing the same
Physica Pharma 2117510*

• Pharmaceutical formulation comprising neurokinin antagonist
Novartis 2117511*

• Stabilised micronised particles
DSM IP Assets 2117512*

• Polymer formulations for delivery of bioactive agents
Carbylan Biosurgery 2117513*

• Compsns comprising PEG-interferon alpha conjugates and raffinose as cryoprotectant
Cadila Healthcare 2117514*

• Method for stabilising blood plasma components in a lyophilisate
Octapharma 2117515*

• Stable atrovastatin formulations
Actavis Group 2117516*

• Sustained release oral dosage forms of a prodrug of R-balofen and methods of treatment
XenoPort 2117517*

• Tablet-in-tablet compsns
Wyeth 2117518*

• Pharmaceutical compsn comprising tramadol and ketoprofen in association
Eurofarma Laboratorios 2117519*

• Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
Abraxis BioScience 2117520*

• Transdermal delivery systems comprising bupivacaine
Durect Corp 2117521*

• Patch for cutaneous application
DBV Technologies 2117522*

• Inhibitors of AKT activity
SmithKline Beecham 2117523*

• Use of catecholamines and related compounds as anti-angiogenic agents
National Research Council of Canada 2117524*

• Use of 1-phenyl-3-dimethylamino-propane compounds for the therapy of neuropathy pain
Gruenenthal 2117525*

• Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
Abbott Laboratories 2117526*

• Methods for treatment of senile dementia of the Alzheimer's type
Phenomenome Discoveries 2117527*

• Use of adenosine deaminase for treating pulmonary disease
Enzon Pharmaceuticals; Board of Regents of the University of Texas System 2117528*

• Method for treating diseases of altered IGE regulation
The Research Foundation of the State University of New York 2117529*

• Compsn comprising a glycolytic inhibitor and a ring system comprising a sulphamate group for the treatment of cancer
Sterix 2117530*

• Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors
AB Science 2117531*

• Chromones as therapeutic agents
Unigen Pharmaceuticals 2117532*

• Pharmaceutical compsn on the basis of Stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo
Ache Laboratorios FarmacEuticos 2117533*

• A pharmaceutical compsn with atorvastatin active ingredient
Zentiva 2117534*

• Novel pharmaceutical compsns
Glaxo Group 2117535*

• Cosmetic and pharmaceutical applications of N-acylated amino acids and structurally related compounds
Beiersdorf 2117536*

• Compounds and compsns as channel activating protease inhibitors
IRM LLC 2117537*

• Pharmaceutical compsns comprising 2-methoxy-5-(5-trifluoromethyl-tatrazol-1-yl-benzyl)-(2S-phenyl-piperidin-3S-yl-)
Glaxo Group 2117538*

• A method of administering an antitumour compound
Nerviano Medical Sciences 2117539*

• New use of glutaminyl cyclase inhibitors
Probiodrug 2117540*

• Compounds and compsns as channel activating protease inhibitors
IRM LLC 2117541*

• Combinations of beta-2-adrenoceptor agonistic benzothiazolone
AstraZeneca 2117542*

• Potentiation of stem cell homing and treatment of organ dysfunction or organ failure
Nephrogen 2117543*

• Biomarker identifying the reactivation of STAT3 after SRC inhibition
Board of Regents of the University of Texas System; Bristol-Myers Squibb 2117544*

• Indenoisoquinolinone analogues and methods of use thereof
Inotek Pharmaceuticals 2117545*

• 1,2,3,4-tetrahydroisoquinoline derivatives having effects of preventing and treating degenerative and inflammatory diseases
University of Ulsan Foundation for Industry Cooperation 2117547*

• Method of treating multidrug resistant cancers
Antisoma Research 2117548*

• Use of ranolazine for the treatment of coronary microvascular diseases
CV Therapeutics 2117549*

• Levosimendan for use in treating chronic valvular disease
Orion 2117551*

• Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases
Stoicescu, Dan 2117552*

• Compsns and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract
Bausch & Lomb 2117553*

• Progesterone for the prevention of preterm birth
Columbia Laboratories (Bermuda) 2117554*

• Use of tri-substituted glycerol compounds for the treatment of haematological malignancies
Universitaetsklinikum Hamburg-Eppendorf 2117555*

• Combination therapy comprising romidepsin and I.A bortezomib
Gloucester Pharmaceuticals 2117556*

• Compsns and methods for treatment of colorectal cancer
The Burnham Institute for Medical Research 2117557*

• Methods of modulating immune function
The Regents of the University of Colorado 2117558*

• Pharmaceutical compsn for the treatment of IL-8 mediated diseases
Revotar Biopharmaceuticals 2117559*

• A compsn for selective serotonin reuptake inhibition and process thereof
Indus Biotech Private Ltd 2117560*